Fresenius GranuFlo and NaturaLyte Whistleblower
GranuFlo False Claims Lawsuit. The whistleblower attorneys at the national law firm Parker Waichman LLP are investigating potential whistleblower lawsuits against Fresenius Medical Care involving its GranuFlo® and NaturaLyte® dialysis products. If a former or current Fresenius employee successfully pursues a Fresenius … [Read more...]
Fresenius Proposes $250M Settlement
Risk of Dialysis Drug Fresenius has agreed to pay $250 million to settle lawsuits alleging it hid information involving the risks of its dialysis drugs, GranuFlo and NaturaLyte. Dialysis is a treatment that essentially acts as an artificial kidney. Patients who have renal failure undergo dialysis in order to remove wastes from the … [Read more...]
Fresenius Dialysis Suits Not Barred by FDA
Fresenius Dialysis Lawsuits. Lawsuits filed over Fresenius' GranuFlo and NaturaLyte dialysis drugs are not barred by a 2012 warning posted by the U.S. Food and Drug Administration (FDA), attorneys representing plaintiffs argued. According to Law360, Fresenius cited the notice as a reason for its efforts to prevent … [Read more...]
Fresenius Over Tainted Dialysis Additives
Lawsuits Against Tainted Dialysis Additives. A growing number of lawsuits are accusing the operators of the nation’s largest kidney dialysis centers of hiding evidence that showed its dialysis additive products, GranuFlo and Naturalyte, were dangerous and likely to cause the death of a patient. According to a … [Read more...]
Fresenius GranuFlo Dialysis & Nauralyte Recalled for Cardiac Arrest
FDA's Class I Recall of GranuFlo & Nauralyte Dialysis ProductsThe U.S. Food & Drug Administration (FDA) has announced a Class I recall for Fresenius Medical Care's NaturaLyte and GranuFlo dialysis products because of their association with life-threatening cardiac arrest events. A Class I recall is the FDA’s most serious recall … [Read more...]
